In this study, we observed that TRAIL expression in ASCs was significantly increased by M1 macrophages, and TRAIL-expressing ASCs could effectively alleviate colon cancer by suppressing CD133+ CSCs and M2 macrophages in the tumor microenvironment. This evidence concerns the gene PROM1 and colonic neoplasm.